Clinical Trial Update: Blood Loss and Transfusion Requirement in Infants Treated With Tranexamic Acid [Phase 3]

View source ↗

Summary

Phase 3 trial update on tranexamic acid in infants with craniosynostosis, focusing on blood loss and transfusion requirements.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Craniosynostosis

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Craniosynostoses | Phase 3 | Status: SUSPENDED